ClinConnect ClinConnect Logo
Search / Trial NCT06519318

Validity And Reliability of The Incremental Shuttle Walk Test In Type 2 Diabetes Mellitus

Launched by ILAYDA KAYAPINAR · Jul 19, 2024

Trial Information

Current as of August 19, 2025

Enrolling by invitation

Keywords

Diabetes Mellitus 6 Minute Walk Test Incremental Shuttle Walk Test Reliability And Validity

ClinConnect Summary

This clinical trial is studying a test called the Incremental Shuttle Walk Test (ISWT) to see how well it works for people with type 2 diabetes. The goal is to check if this walking test is reliable and valid for measuring how well someone can walk and how their health is doing. Participants will first have their health information recorded and then take the ISWT and another walking test, with a break in between. A week later, they will come back to do the ISWT again to see if the results are consistent.

To be eligible for this trial, participants should be between 65 and 74 years old, have a specific level of blood sugar control (measured by HbA1c between 6.5 and 11), and be able to walk on their own. Unfortunately, people with certain health issues, like uncontrolled diabetes or serious heart and lung conditions, as well as those who are pregnant or have severe problems with their muscles or nerves, will not be able to participate. This study is still in the planning stages and has not started recruiting participants yet.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • HbA1c between 6.5 and 11
  • No mental problems
  • Able to walk independently
  • Exclusion Criteria:
  • Lack of co-operation
  • Uncontrolled diabetes,
  • Patients with uncontrolled hypotension or hypertension
  • Unstable cardiovascular and pulmonary conditions
  • Having vertigo and various vestibular system disorders
  • Those with severe neurological or severe respiratory diseases
  • Patients with major musculoskeletal problems
  • Pregnant women

About Ilayda Kayapinar

Ilayda Kayapinar is a dedicated clinical trial sponsor focused on advancing medical research and innovation. With a strong commitment to ethical standards and regulatory compliance, the organization actively collaborates with healthcare professionals, researchers, and institutions to design and implement clinical trials that aim to evaluate new therapies and interventions. Leveraging a robust network and expertise in clinical operations, Ilayda Kayapinar strives to enhance patient outcomes and contribute to the scientific community through rigorous data collection and analysis, ultimately fostering the development of breakthrough treatments in various therapeutic areas.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Melis USUL, RA

Principal Investigator

Istanbul Kent Universty

Gülenay YILDIRIM, RA

Principal Investigator

Istanbul Galata Universty

Gökşen KURAN ASLAN, Prof

Study Director

Istanbul Universty-Cerrahpaşa

Semiramis Özyılmaz, Assoc Prof

Study Director

Bezmaialem Foundation University

Muhammed TUNÇ, Asst Prof

Principal Investigator

Bezmaialem Foundation University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported